Early assessment of induction chemotherapy response of nasopharyngeal carcinoma by pretreatment diffusion-weighted magnetic resonance imaging

Journal of Computer Assisted Tomography

Volumn 37, Issue 5, 2013, Pages 673-680

  Zheng, Dechun ^a   Chen, Yunbin ^a   Chen, Ying ^a   Xu, Luying ^a   Lin, Fengjie ^a   Lin, Jin ^a   Huang, Chaobin ^a   Pan, Jianji ^a  

^a Fujian Provincial Cancer Hospital   (China)

Author keywords

apparent diffusion coefficient; diffusion weighted imaging; induction chemotherapy; nasopharyngeal carcinoma

Indexed keywords

CHEMORADIOTHERAPY; FORECASTING; INTEGRATED CIRCUITS; MAGNETIC RESONANCE IMAGING; SURFACE DIFFUSION;

APPARENT DIFFUSION COEFFICIENT; CHEMOTHERAPY RESPONSE; COEFFICIENT VALUES; DIFFUSION WEIGHTED IMAGING; DIFFUSION-WEIGHTED MAGNETIC RESONANCE; HIGH SENSITIVITY; INDUCTION CHEMOTHERAPY; NASOPHARYNGEAL CARCINOMA; PRE-TREATMENTS; STAGE III;

CHEMOTHERAPY;

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CETUXIMAB; CISPLATIN; FLUOROURACIL; GADOLINIUM; GEMCITABINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISTANT METASTASIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

EID: 84885000560     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31829a2599     Document Type: Article

References (29)

1. Xiao WW, Lu TX, Zhao C, et al. Impact of intensity-modulated radiotherapy on the 6th edition of UICC/AJCC staging system in nasopharyngeal carcinoma[J]. China J of Radiat Oncol. 2010;19: 181-184.
2. Pignon JP, le Maitre A, Bourhis J. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys. 2007;69:S112-S114. (Pubitemid 47369400)
3. Cohen E, Karrison T, Kocherginsky M, et al. DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol. 2012;30(suppl; abstr 5500).
4. Chua DT, Ma J, Sham JS, et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials. Int J Radiat Oncol Biol Phys. 2006;65:1300-1306. (Pubitemid 44425202)
5. Chua DT, Ma J, Sham JS, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol. 2005;23:1118-1124. (Pubitemid 46202267)
6. Lin S, Lu JJ, Han L, et al. Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer. 2010;10:39.
7. Buffa FM, Bentzen SM, Daley FM, et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res. 2004;10:3745-3754. (Pubitemid 38697608)
8. Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 1997;390:404-407. (Pubitemid 28027321)
9. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol. 2010;20:1703-1714.
10. Kim S, Loevner LA, Quon H, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2010;31:262-268.
11. Powell C, Schmidt M, Borri M, et al. Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol. 2013;106:112-117.
12. Lin C, Itti E, Luciani A, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol. 2011;46:341-349.
13. Kim JH, Kim CK, Park BK, et al. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy. Eur Radiol. 2012;22:2533-2539.
14. Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006;24:843-847. (Pubitemid 44205378)
15. Sharma U, Danishad KK, Seenu V, et al. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed. 2008;22:104-113.
16. Maeda M, Kato H, Sakuma H, et al. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head andneck. AJNR Am J Neuroradiol. 2005;26:1186-1192. (Pubitemid 43821971)
17. King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology. 2007;245:806-813. (Pubitemid 350127351)
18. Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol. 2007;28:1146-1152. (Pubitemid 46984559)
19. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys. 2007;67:960-971.
20. Mardor Y, Roth Y, Ochershvilli A, et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia. 2004;6:136-142. (Pubitemid 38544601)
21. Park SH, Moon WK, Cho N, et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology. 2010;257:56-63.
22. McVeigh PZ, Syed AM, Milosevic M, et al. Diffusion-weighted MRI in cervical cancer. Eur Radiol. 2008;18:1058-1064.
23. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.
24. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.
25. Hatakenaka M, Nakamura K, Yabuuchi H, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys. 2011;81:339-345.
26. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol. 2010;20:2213-2220.
27. Chawla S, Kim S, Dougherty L, et al. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol. 2013;200:35-43.
28. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.
29. Deng J, Miller FH, Salem R, et al. Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol. 2006;41:769-775. (Pubitemid 44401304)